Obagi Medical Products, Inc. (NASDAQ:OMPI)
CAPS Rating:
A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.
A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.
Recs
This undervalued skin care company with a fairly strong financial statement will appreciate a minimum of 15% each year over the next five years. It is so low that a much larger company could try to purchase this to take advantage of its lineup.